KUALA LUMPUR — Preliminary data from a French randomized trial suggest that early HIV treatment might be a step toward so-called post-treatment control, a researcher said here.
Post-treatment control is what investigators are calling the ability to stop HIV therapy — after some time on treatment — without having the virus resume replication within the body.
Some 14 patients — known as the Visconti cohort and all treated within weeks of their infection — have been shown to have such control, some for several years, according to Antoine Cheret, MD, of Sorbonne-Paris-Cite University in Paris.
At the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention here, Cheret presented early data from the first randomized trial aimed at duplicating the Visconti cohort.
Michael Smith
North American Correspondent
MedPage Today
Read More